BRCA2 and cancer: While BRCA2-associated cancers are predominantly hormone receptor-positive tumors, BRCA1-associated tumors are more frequently classified as triple-negative breast cancer (TNBC), a subtype known for its aggressive nature and higher sensitivity to neoadjuvant chemotherapy [2,3].